title: Neonatal hypoglycaemia in severe succinyl-CoA: 3-oxoacid CoA-transferase deficiency.
abstract: Succinyl-CoA: 3-oxoacid CoA-transferase (SCOT) deficiency is an inborn error of ketone body utilization, characterized by intermittent ketoacidotic crises and persistent ketosis. The diagnosis was suspected in a patient who presented with hypoglycaemia, ketoacidosis and coma at 4 days of age. The hypoglycaemic tendency was only observed during the first month of life. A novel macromolecular labelling assay in cultured skin fibroblasts using D-3-hydroxy[3-14C]butyrate supported the diagnosis. Subsequently, 9% residual SCOT activity and undetectable cross-reactive protein were noted in fibroblasts and the patient was found to be homozygous for the G324E SCOT gene mutation. By 7 years of age, recurrent episodes of ketoacidosis superimposed on persistent hyperketonaemia had resulted in over 25 hospitalizations requiring intravenous fluid, glucose and sodium bicarbonate therapy. He has had normal growth but developmental delay and attention deficit-hyperactivity disorder. A continuous intravenous glucose infusion at 38 microlmol (6.8 mg)/kg per min reduced plasma total ketone levels from greater than 1.5 mmol/L to less than 0.5 mmol/L after 48 h. This indicates that patients with SCOT deficiency do not always manifest ketosis with administration of a sufficient amount of carbohydrates, but that even under such conditions hyperketonaemia is difficult to eliminate completely. The presence of hypoglycaemia does not exclude the diagnosis of SCOT deficiency in infancy.
authors.affiliation: Department of Pediatrics, University of Pennsylvania School of Medicine, The Children's Hospital of Philadelphia, 19104, USA. berry@email.chop.edu
authors.forename: G T
authors.initials: GT
authors.lastname: Berry
authors.forename: T
authors.initials: T
authors.lastname: Fukao
authors.forename: G A
authors.initials: GA
authors.lastname: Mitchell
authors.forename: A
authors.initials: A
authors.lastname: Mazur
authors.forename: M
authors.initials: M
authors.lastname: Ciafre
authors.forename: J
authors.initials: J
authors.lastname: Gibson
authors.forename: N
authors.initials: N
authors.lastname: Kondo
authors.forename: M J
authors.initials: MJ
authors.lastname: Palmieri
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000209:etiology; D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000000981:diagnostic imaging; D002648:Child; D015256:Coenzyme A-Transferases / Q000172:deficiency* / Q000235:genetics*; D005947:Glucose / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia / Q000178:diet therapy / Q000201:enzymology / Q000235:genetics*; D015151:Immunoblotting; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D007657:Ketone Bodies / Q000097:blood; D007930:Leucine; D008661:Metabolism, Inborn Errors / Q000178:diet therapy / Q000201:enzymology / Q000235:genetics*; D014057:Tomography, X-Ray Computed
chemical_list: D001786:Blood Glucose; D007328:Insulin; D007657:Ketone Bodies; D015256:Coenzyme A-Transferases; C021460:3-ketoacid CoA-transferase; D007930:Leucine; D005947:Glucose